Needles Market Significantly Growing Across The World
The needles market is expected to reach USD 8.47 Billion by 2022 from USD 5.82 Billion in 2017, at a CAGR of 7.8% during the forecast period. Base year considered for the report is 2016 and forecast year is 2022.
Hamilton Company (U.S.), Medtronic plc (Ireland), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S.), Terumo Corporation (Japan), Novo Nordisk A/s (Denmark), Smiths Medical (U.K.), and Thermo Fisher Scientific (U.S.) are some of the key players in the global needles market.
These players are striving to expand their presence in the emerging countries of Asia and the Middle East & North Africa (MENA) region through product launches, partnerships, product approvals, and collaborations.
Stakeholders
Needle manufacturers, suppliers, and distributors
Injectable device manufacturers, suppliers, and distributors
Healthcare institutions (hospitals and outpatient clinics)
Clinical centers
Pharmaceuticals companies
Medical research laboratories
Consulting firms
Geographically, emerging Asian countries offer high-growth opportunities for market players. As of 2017. The conducive regulatory policies for the approval of new injectables and rapid growth in the geriatric population are key factors influencing the growth of the Asia-Pacific needles market.
Speak to Our Expert @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=223979930
